• Kaneka's six-month net income attributable to owners of parent rose 33% year-over-year to JPY 14.65 billion through September 30, 2026.
• Operating income jumped 92% year-over-year to JPY 28.68 billion, while ordinary income more than doubled to JPY 24.32 billion.
• Net sales climbed 13% year-over-year to JPY 446.97 billion, with all business units recording higher first-half sales and profits.
• Medical profit increased substantially due to expanding sales of blood purification devices and catheters; overseas sales also expanded.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaneka Corporation published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.